Related Experiment Video
Updated: Apr 6, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a
Marius Irimie1, Alexandru Oanta, Claudia Alexandrina Irimie
1Marius Irimie Irimie, MD, 40, Zizinului Street, Brasov, Romania; marius_irimie2002@yahoo.com.
Abstract:
Patients with neoplasia who are severely immunocompromised have a higher risk of fungal infections. There are limited data in the literature regarding the frequency of dermatophyte infections and efficacy of antifungals in patients with malignancies. Objective was assessment of the incidence of dermatophyte infections and antifungal susceptibility, determination of dermatophyte species isolated from patients with neoplastic diseases. 138 patients diagnosed with various malignancies and 160 immunocompetent patients who were referred to the Department of Dermatology in Brasov, Romania, for suspicion of dermatophyte infections were included in the study. Nail clippings or skin scrapings were examined by direct microscopy and cultures in Sabouraud agar medium. Susceptibility tests for antifungals were conducted in vitro using a method of broth microdilution. Infections with dermatophytes were identified in 30.4% of patients with neoplastic diseases and in 29.37% in the control group. There was a significantly higher frequency of dermatophyte infections in patients with hematologic malignancies (52%) compared to those with solid cancers (25.66%) (P=0.01). The clinical aspects of dermatophyte infections in patients with neoplastic diseases were not different from those of patients without cancer; though in some cases the infections were more extensive. There were no statistically significant differences between mean values of minimum inhibitory concentration of antifungals compared with controls. Terbinafine had the highest antidermatophyte activity for all tested dermatophyte species isolated from patients with neoplastic diseases. There were no differences in frequency of dermatophyte infections and antifungal susceptibility to dermatophytes between patients with neoplastic diseases and immunocompetent patients.
Insights
Patients with cancer, especially hematologic malignancies, face a higher risk of fungal infections like dermatophytosis. Antifungal susceptibility remains similar to the general population, with terbinafine showing the most effectiveness.
Area of Science:
- Mycology
- Dermatology
- Oncology
Background:
- Severely immunocompromised patients with neoplasia are at increased risk for fungal infections.
- Limited data exist on dermatophyte infection frequency and antifungal efficacy in cancer patients.
Purpose of the Study:
- To assess the incidence of dermatophyte infections in cancer patients.
- To determine antifungal susceptibility and identify dermatophyte species in this population.
- To compare findings with immunocompetent individuals.
Main Methods:
- Direct microscopy and Sabouraud agar cultures of nail/skin samples from 138 cancer patients and 160 controls.
- In vitro antifungal susceptibility testing using broth microdilution.
- Analysis of clinical presentation and species identification.
Main Results:
- Dermatophyte infections occurred in 30.4% of cancer patients vs. 29.37% of controls.
- Hematologic malignancy patients had a significantly higher infection rate (52%) than solid cancer patients (25.66%).
- Terbinafine demonstrated the highest in vitro antifungal activity.
Conclusions:
- Cancer patients, particularly those with hematologic malignancies, show a higher incidence of dermatophytosis.
- Antifungal susceptibility patterns in cancer patients are comparable to immunocompetent individuals.
- Clinical presentation may be more extensive in cancer patients, but terbinafine remains a key treatment option.
More Related Videos
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Antifungal Agents
Fungal Phylum Microsporidia
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

